GOLDSMITH MARK A bought RVMD
October 16, 2025 · Form 4 insider transaction
GOLDSMITH MARK A bought 10,000 shares of Revolution Medicines, Inc. at $1.12 per share, a transaction worth $11.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$1.12
Total value
$11.2K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 16, 2025
Filing dateOctober 20, 2025
Shares owned after462,309
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 193,475 restricted stock units.